Karuna Therapeutics Sees Breakthrough In Schizophrenia Drug
Karuna Therapeutics' top-experimental schizophrenia drug significantly reduced symptoms in a late-stage trial but there were concerns that it could cause hypertension in patients.
The Environmental Protection Agency said it has revised a key rule relating to the nation's waters that would weaken efforts to protect acres of wetlands.